B2B
Stipple Bio
United Statesstipple.bio
Stipple Bio develops AI-driven spatial proteomics technologies to precisely identify tumor-specific epitopes, aiming to accelerate targeted oncology drug development and biomarker discovery.
aliveseries-a
series-a
Stage
2
Funding Rounds
About
Stipple Bio develops AI-driven spatial proteomics technologies to precisely identify tumor-specific epitopes, aiming to accelerate targeted oncology drug development and biomarker discovery.
Explore Stipple Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.